|
NACC1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | <1E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
<1E-12 |
| Normal-vs-Stage2 |
6.35602681597902E-12 |
| Normal-vs-Stage3 |
1.62436730732907E-12 |
| Normal-vs-Stage4 |
1.62503344114384E-12 |
| Stage1-vs-Stage2 |
4.611600E-01 |
| Stage1-vs-Stage3 |
8.104400E-01 |
| Stage1-vs-Stage4 |
6.454000E-02 |
| Stage2-vs-Stage3 |
6.131000E-01 |
| Stage2-vs-Stage4 |
3.992800E-01 |
| Stage3-vs-Stage4 |
1.286630E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
<1E-12 |
| Normal-vs-AfricanAmerican |
4.93840002224744E-09 |
| Normal-vs-Asian |
1.76891834513526E-12 |
| Caucasian-vs-AfricanAmerican |
2.041200E-01 |
| Caucasian-vs-Asian |
8.001600E-01 |
| AfricanAmerican-vs-Asian |
3.452000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
<1E-12 |
| Normal-vs-Female |
<1E-12 |
| Male-vs-Female |
8.324000E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.62436730732907E-12 |
| Normal-vs-Age(41-60Yrs) |
<1E-12 |
| Normal-vs-Age(61-80Yrs) |
<1E-12 |
| Normal-vs-Age(81-100Yrs) |
1.64709999972423E-07 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.166000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.897400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.633200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.325600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.058000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.018000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
3.889200E-01 |
| Classical-VS-Follicular |
3.6495999999997E-05 |
| Classical-VS-Other |
4.039200E-01 |
| Classical-VS-Normal |
1.62436730732907E-12 |
| Tall-VS-Follicular |
9.441900E-02 |
| Tall-VS-Other |
7.258200E-01 |
| Tall-VS-Normal |
2.5997999975047E-08 |
| Follicular-VS-Other |
5.761200E-01 |
| Follicular-VS-Normal |
3.05879765960526E-11 |
| Other-VS-Normal |
4.09670000000029E-05 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.62447832963153E-12 |
| Normal-vs-N1 |
1.69959601947767E-11 |
| N0-vs-N1 |
7.740000E-01 |
|
|
